Results 91 to 100 of about 12,309 (198)

Brincidofovir in the Era of Mpox

Expert Review of Anti-infective Therapy
Mpox (formerly monkeypox), a systemic infection caused by the mpox virus (MPXV), has become a global problem of increasing concern. There are currently no antiviral treatments that have been shown to be safe and effective for the treatment of mpox.Brincidofovir is a lipid-modified acyclic nucleotide with in vitro and in vivo activity against multiple ...
James, McCarty, David, Cassie, Shantha, Kodihalli, Efe, Aigbedo, Jing, Tian, Kevin, Yeo, Vanja, Komlenovic, Lovelyn, Charles, Bojan, Drobic, Bob, Warnock   +9 more
openaire   +2 more sources

Clinical considerations for pain management of mpox [PDF]

Updated March 27, 2023Symptomatic Manifestations of Mpox -- Complications of Mpox -- General Considerations for Pain Management -- Genital Lesions -- Oropharyngeal lesions -- Pruritis / Itching ...

core  

The Peculiar Emergence of Mpox (Monkeypox): Directions for the Search for the Natural Reservoir and Vaccination Strategies

Vaccines
Background/Objectives: Mpox (monkeypox) is a zoonosis with origins in a currently unknown African reservoir. The first epidemiological accounts of mpox date back to the early 1980s, yet mpox only emerged as a pandemic threat in 2022–2023, more than 40 ...
Romulus Breban
doaj   +1 more source

The Mpox vaccine (JYNNEOS vaccine) [PDF]

Mpox (formerly known as monkeypox) is caused by a virus that is related to the virus that causes smallpox. JYNNEOS is a 2-dose vaccine that was developed to protect against both mpox and smallpox. People need to get both doses of the vaccine for the best

core   +2 more sources

Mpox epidemiology, barriers to treatment and prevention, and perceived stigma: a cross-sectional study

BMC Public Health
Background The 2022 mpox outbreak in the United States primarily affected sexual minority men. Barrier to healthcare access, treatment, and vaccination against mpox are not well characterized. Stigma surrounding mpox has not been well quantified, and may
Angelique E. Boutzoukas, Pedro A. Serrano, Alfred Cortez, Princess Abbott-Grimes, Dylan Thibault, Emily M. D’Agostino, Christoph Hornik, Gregory Phillips II   +7 more
doaj   +1 more source

The epidemiological and clinical differences between patients with mpox and patients without mpox among suspected cases during the recent global mpox outbreaks: a systematic review and meta-analysis

Frontiers in Cellular and Infection Microbiology
BackgroundThe recent mpox outbreaks have brought challenges to the global health system. We aimed to study the epidemiological and clinical differences between patients with mpox and patients without mpox among suspected cases during and after 2022 ...
Yingying Han, Xingzhao Li, Xin Wang, Zhuan Zhong   +3 more
doaj   +1 more source

Epidemiology of Mpox during the current outbreak [PDF]

Mpox-02-Ellington-508 ...

core  

J Public Health Manag Pract

Context:In response to the first reported mpox cases in May 2022, the United States Government (USG) implemented plans to bring testing, treatment, and vaccines to communities disproportionately affected by mpox\u2014including the population of men who ...

core  

JYNNEOS vaccine safety monitoring during the 2022 Mpox outbreak \u2500 United States

Mpox-03-Duffy-508 ...

core  

Mpox : intervention services for people with or exposed to mpox

Updated February 2, 2023Much of the scientific understanding of mpox transmission in the US is in progress or development. In the current mpox outbreak, the virus is spreading primarily through close personal contact, in particular skin-to-skin contact ...

core